Preferences of patients, clinicians, and healthy controls for the management of a Bethesda III thyroid nodule
Background Active surveillance is propagated as an alternative for hemithyroidectomy in the management of Bethesda III thyroid nodules. Methods A cross‐sectional survey questioned respondents on their willingness to accept risks related to active surveillance and hemithyroidectomy. Results In case o...
Gespeichert in:
| Veröffentlicht in: | Head & neck 2023-07, Vol.45 (7), p.1772-1781 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1781 |
|---|---|
| container_issue | 7 |
| container_start_page | 1772 |
| container_title | Head & neck |
| container_volume | 45 |
| creator | Kinschot, Caroline M. J. Soekhai, Vikas R. Bekker‐Grob, Esther W. Visser, W. Edward Peeters, Robin P. Noord, Charlotte Ginhoven, Tessa M. |
| description | Background
Active surveillance is propagated as an alternative for hemithyroidectomy in the management of Bethesda III thyroid nodules.
Methods
A cross‐sectional survey questioned respondents on their willingness to accept risks related to active surveillance and hemithyroidectomy.
Results
In case of active surveillance, respondents (129 patients, 46 clinicians, and 66 healthy controls) were willing to accept a risk of 10%–15% for thyroid cancer and 15% for needing more extensive surgery in the future. Respondents were willing to accept a risk of 22.5%–30% for hypothyroidism after hemithyroidectomy. Patients and controls were willing to accept a higher risk on permanent voice changes compared with clinicians (10% vs. 3%, p |
| doi_str_mv | 10.1002/hed.27389 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2811570507</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2811570507</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3889-2e43be088f864b04c16a9620875618bc1a304e2112f4c2971fde6be90cfec5cd3</originalsourceid><addsrcrecordid>eNp1kU1r3DAQhkVpaDZpDv0DRdBLAnEy-rAlH_O9CwvJoTkbWR53vdjSVrIJ---jzSaXQE4zDM88DPMS8ovBBQPglytsLrgSuvxGZgxKlYGQ6vuulyIToOQhOYpxDQCikPwHORSK5VowNSPDU8AWAzqLkfqWbszYoRvjObV95zrbGZd64xq6QtOPqy213o3B95G2PtBxhXQwzvzDIW3tBIZeY5rGxtDFYpGAbfBdQ51vph5_koPW9BFP3usxeb6_-3szz5aPD4ubq2VmhdZlxlGKGkHrVheyBmlZYcqCg1Z5wXRtmREgkTPGW2l5qVjbYFFjCbZFm9tGHJPTvXcT_P8J41gNXbTY98ahn2LFNWO5ghxUQv98Qtd-Ci5dlyjOy7wQTCfqbE_Z4GNML6s2oRtM2FYMql0GVcqgessgsb_fjVM9pOkH-fH0BFzugZeux-3Xpmp-d7tXvgL474-P</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2822956318</pqid></control><display><type>article</type><title>Preferences of patients, clinicians, and healthy controls for the management of a Bethesda III thyroid nodule</title><source>Wiley Journals</source><creator>Kinschot, Caroline M. J. ; Soekhai, Vikas R. ; Bekker‐Grob, Esther W. ; Visser, W. Edward ; Peeters, Robin P. ; Noord, Charlotte ; Ginhoven, Tessa M.</creator><creatorcontrib>Kinschot, Caroline M. J. ; Soekhai, Vikas R. ; Bekker‐Grob, Esther W. ; Visser, W. Edward ; Peeters, Robin P. ; Noord, Charlotte ; Ginhoven, Tessa M.</creatorcontrib><description>Background
Active surveillance is propagated as an alternative for hemithyroidectomy in the management of Bethesda III thyroid nodules.
Methods
A cross‐sectional survey questioned respondents on their willingness to accept risks related to active surveillance and hemithyroidectomy.
Results
In case of active surveillance, respondents (129 patients, 46 clinicians, and 66 healthy controls) were willing to accept a risk of 10%–15% for thyroid cancer and 15% for needing more extensive surgery in the future. Respondents were willing to accept a risk of 22.5%–30% for hypothyroidism after hemithyroidectomy. Patients and controls were willing to accept a higher risk on permanent voice changes compared with clinicians (10% vs. 3%, p < 0.001).
Conclusion
Real‐life risks associated which active surveillance and hemithyroidectomy for Bethesda III nodules are equivalent or less than the risks people are willing to accept. Clinicians accepted less risk for permanent voice changes.</description><identifier>ISSN: 1043-3074</identifier><identifier>EISSN: 1097-0347</identifier><identifier>DOI: 10.1002/hed.27389</identifier><identifier>PMID: 37158317</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley & Sons, Inc</publisher><subject>active surveillance ; Bethesda III ; hemithyroidectomy ; Hypothyroidism ; Nodules ; Thyroid cancer ; thyroid nodule ; treatment preferences</subject><ispartof>Head & neck, 2023-07, Vol.45 (7), p.1772-1781</ispartof><rights>2023 The Authors. published by Wiley Periodicals LLC.</rights><rights>2023 The Authors. Head & Neck published by Wiley Periodicals LLC.</rights><rights>2023. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3889-2e43be088f864b04c16a9620875618bc1a304e2112f4c2971fde6be90cfec5cd3</citedby><cites>FETCH-LOGICAL-c3889-2e43be088f864b04c16a9620875618bc1a304e2112f4c2971fde6be90cfec5cd3</cites><orcidid>0000-0002-0520-7698</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fhed.27389$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fhed.27389$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37158317$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kinschot, Caroline M. J.</creatorcontrib><creatorcontrib>Soekhai, Vikas R.</creatorcontrib><creatorcontrib>Bekker‐Grob, Esther W.</creatorcontrib><creatorcontrib>Visser, W. Edward</creatorcontrib><creatorcontrib>Peeters, Robin P.</creatorcontrib><creatorcontrib>Noord, Charlotte</creatorcontrib><creatorcontrib>Ginhoven, Tessa M.</creatorcontrib><title>Preferences of patients, clinicians, and healthy controls for the management of a Bethesda III thyroid nodule</title><title>Head & neck</title><addtitle>Head Neck</addtitle><description>Background
Active surveillance is propagated as an alternative for hemithyroidectomy in the management of Bethesda III thyroid nodules.
Methods
A cross‐sectional survey questioned respondents on their willingness to accept risks related to active surveillance and hemithyroidectomy.
Results
In case of active surveillance, respondents (129 patients, 46 clinicians, and 66 healthy controls) were willing to accept a risk of 10%–15% for thyroid cancer and 15% for needing more extensive surgery in the future. Respondents were willing to accept a risk of 22.5%–30% for hypothyroidism after hemithyroidectomy. Patients and controls were willing to accept a higher risk on permanent voice changes compared with clinicians (10% vs. 3%, p < 0.001).
Conclusion
Real‐life risks associated which active surveillance and hemithyroidectomy for Bethesda III nodules are equivalent or less than the risks people are willing to accept. Clinicians accepted less risk for permanent voice changes.</description><subject>active surveillance</subject><subject>Bethesda III</subject><subject>hemithyroidectomy</subject><subject>Hypothyroidism</subject><subject>Nodules</subject><subject>Thyroid cancer</subject><subject>thyroid nodule</subject><subject>treatment preferences</subject><issn>1043-3074</issn><issn>1097-0347</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><recordid>eNp1kU1r3DAQhkVpaDZpDv0DRdBLAnEy-rAlH_O9CwvJoTkbWR53vdjSVrIJ---jzSaXQE4zDM88DPMS8ovBBQPglytsLrgSuvxGZgxKlYGQ6vuulyIToOQhOYpxDQCikPwHORSK5VowNSPDU8AWAzqLkfqWbszYoRvjObV95zrbGZd64xq6QtOPqy213o3B95G2PtBxhXQwzvzDIW3tBIZeY5rGxtDFYpGAbfBdQ51vph5_koPW9BFP3usxeb6_-3szz5aPD4ubq2VmhdZlxlGKGkHrVheyBmlZYcqCg1Z5wXRtmREgkTPGW2l5qVjbYFFjCbZFm9tGHJPTvXcT_P8J41gNXbTY98ahn2LFNWO5ghxUQv98Qtd-Ci5dlyjOy7wQTCfqbE_Z4GNML6s2oRtM2FYMql0GVcqgessgsb_fjVM9pOkH-fH0BFzugZeux-3Xpmp-d7tXvgL474-P</recordid><startdate>202307</startdate><enddate>202307</enddate><creator>Kinschot, Caroline M. J.</creator><creator>Soekhai, Vikas R.</creator><creator>Bekker‐Grob, Esther W.</creator><creator>Visser, W. Edward</creator><creator>Peeters, Robin P.</creator><creator>Noord, Charlotte</creator><creator>Ginhoven, Tessa M.</creator><general>John Wiley & Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>24P</scope><scope>WIN</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0520-7698</orcidid></search><sort><creationdate>202307</creationdate><title>Preferences of patients, clinicians, and healthy controls for the management of a Bethesda III thyroid nodule</title><author>Kinschot, Caroline M. J. ; Soekhai, Vikas R. ; Bekker‐Grob, Esther W. ; Visser, W. Edward ; Peeters, Robin P. ; Noord, Charlotte ; Ginhoven, Tessa M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3889-2e43be088f864b04c16a9620875618bc1a304e2112f4c2971fde6be90cfec5cd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>active surveillance</topic><topic>Bethesda III</topic><topic>hemithyroidectomy</topic><topic>Hypothyroidism</topic><topic>Nodules</topic><topic>Thyroid cancer</topic><topic>thyroid nodule</topic><topic>treatment preferences</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kinschot, Caroline M. J.</creatorcontrib><creatorcontrib>Soekhai, Vikas R.</creatorcontrib><creatorcontrib>Bekker‐Grob, Esther W.</creatorcontrib><creatorcontrib>Visser, W. Edward</creatorcontrib><creatorcontrib>Peeters, Robin P.</creatorcontrib><creatorcontrib>Noord, Charlotte</creatorcontrib><creatorcontrib>Ginhoven, Tessa M.</creatorcontrib><collection>Wiley Online Library (Open Access Collection)</collection><collection>Wiley Online Library Free Content</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Head & neck</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kinschot, Caroline M. J.</au><au>Soekhai, Vikas R.</au><au>Bekker‐Grob, Esther W.</au><au>Visser, W. Edward</au><au>Peeters, Robin P.</au><au>Noord, Charlotte</au><au>Ginhoven, Tessa M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Preferences of patients, clinicians, and healthy controls for the management of a Bethesda III thyroid nodule</atitle><jtitle>Head & neck</jtitle><addtitle>Head Neck</addtitle><date>2023-07</date><risdate>2023</risdate><volume>45</volume><issue>7</issue><spage>1772</spage><epage>1781</epage><pages>1772-1781</pages><issn>1043-3074</issn><eissn>1097-0347</eissn><abstract>Background
Active surveillance is propagated as an alternative for hemithyroidectomy in the management of Bethesda III thyroid nodules.
Methods
A cross‐sectional survey questioned respondents on their willingness to accept risks related to active surveillance and hemithyroidectomy.
Results
In case of active surveillance, respondents (129 patients, 46 clinicians, and 66 healthy controls) were willing to accept a risk of 10%–15% for thyroid cancer and 15% for needing more extensive surgery in the future. Respondents were willing to accept a risk of 22.5%–30% for hypothyroidism after hemithyroidectomy. Patients and controls were willing to accept a higher risk on permanent voice changes compared with clinicians (10% vs. 3%, p < 0.001).
Conclusion
Real‐life risks associated which active surveillance and hemithyroidectomy for Bethesda III nodules are equivalent or less than the risks people are willing to accept. Clinicians accepted less risk for permanent voice changes.</abstract><cop>Hoboken, USA</cop><pub>John Wiley & Sons, Inc</pub><pmid>37158317</pmid><doi>10.1002/hed.27389</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-0520-7698</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1043-3074 |
| ispartof | Head & neck, 2023-07, Vol.45 (7), p.1772-1781 |
| issn | 1043-3074 1097-0347 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2811570507 |
| source | Wiley Journals |
| subjects | active surveillance Bethesda III hemithyroidectomy Hypothyroidism Nodules Thyroid cancer thyroid nodule treatment preferences |
| title | Preferences of patients, clinicians, and healthy controls for the management of a Bethesda III thyroid nodule |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T14%3A40%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Preferences%20of%20patients,%20clinicians,%20and%20healthy%20controls%20for%20the%20management%20of%20a%20Bethesda%20III%20thyroid%20nodule&rft.jtitle=Head%20&%20neck&rft.au=Kinschot,%20Caroline%20M.%20J.&rft.date=2023-07&rft.volume=45&rft.issue=7&rft.spage=1772&rft.epage=1781&rft.pages=1772-1781&rft.issn=1043-3074&rft.eissn=1097-0347&rft_id=info:doi/10.1002/hed.27389&rft_dat=%3Cproquest_cross%3E2811570507%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2822956318&rft_id=info:pmid/37158317&rfr_iscdi=true |